Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Pathalys Pharma Inc.
Sponsor

Pathalys Pharma Inc.

United States 4000 Center At North Hills Street, 27609-7093, United States

About the sponsor

Pathalys Pharma Inc. focuses on clinical research in ESKD populations receiving maintenance hemodialysis, with attention to complications that arise in advanced kidney failure.

  • Chronic hemodialysis populations
  • Kidney failure-related complications

The sponsor’s active studies are centered on patients with advanced renal disease in dialysis settings across multiple collaborating sites.

About Specializations

Pathalys Pharma Inc. runs clinical trials in conditions such as Hyperparathyroidism secondary, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Hyperparathyroidism secondary

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Upacicalcet Sodium Hydrate
  • Sponsor:Pathalys Pharma Inc.

Hyperparathyroidism secondary

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Upacicalcet Sodium Hydrate
  • Sponsor:Pathalys Pharma Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.